CAESAREA, Israel, Dec. 1, 2016 /PRNewswire/ — OrthoSpace, Ltd. (http://orthospace.co.il/), a global innovative shoulder implant company, today announces that it has closed on a $7 million equity financing round.  The funds will be used to support the ongoing US Investigational Device Exemption (IDE) FDA Study, build out the Company’s commercial activities in Europe, South America and Asia and provide working capital.  Existing investors, HealthpointCapital LLC, […]